{"id":23289,"date":"2024-11-18T12:37:42","date_gmt":"2024-11-18T04:37:42","guid":{"rendered":"https:\/\/www.1ai.net\/?p=23289"},"modified":"2024-11-18T12:37:42","modified_gmt":"2024-11-18T04:37:42","slug":"%e6%88%91%e5%9b%bd%e5%88%9b%e6%96%b0%e8%8d%af%e5%b8%82%e5%9c%ba%e8%a7%84%e6%a8%a1%e7%aa%81%e7%a0%b4-1000-%e4%ba%bf%e5%85%83%ef%bc%8c%e5%b0%86%e6%8e%a8%e5%8a%a8%e7%94%9f%e7%89%a9%e5%90%88%e6%88%90","status":"publish","type":"post","link":"https:\/\/www.1ai.net\/en\/23289.html","title":{"rendered":"China's innovative drug market scale exceeded 100 billion yuan, will promote biosynthesis, gene editing, AI pharmaceutical and other cutting-edge technology transformation"},"content":{"rendered":"

According to a CCTV news report, the 2024 China Pharmaceutical Industry Development Conference, held in Shanghai on November 16, revealed thatThe number of new drugs under development in China now jumps to the second place in the world<\/strong>.<\/p>\n

\"251eb181j00sn4q5v0014d000in00dzp\"<\/p>\n

In September this year, the national pharmaceutical industry value-added growth rate reached 10.5%, accounting for the proportion of all industries reached 3.7%.<\/p>\n

Jin Zhuanglong, Minister of Industry and Information Technology, said that accelerating the industrialization process of major innovative products, coordinating the complementary and strong chains, and solidly carrying out collaborative research and development in the upstream and downstream of the industrial chain.Promote the transformation of cutting-edge technologies such as biosynthesis, gene editing, AI pharmaceuticals, etc.<\/strong>.<\/p>\n

The Ministry of Industry and Information Technology said that the next step will be to promote the transformation and upgrading of the pharmaceutical industry, enhance the capacity of pharmaceutical production and supply, strengthen the research and development and production of drugs in clinical shortages, children's drugs and drugs for rare diseases, increase the production capacity reserve, and further expand the opening up of the pharmaceutical industry and cooperation.<\/p>\n

Checking the statistics of the Ministry of Industry and Information Technology, it was learned that so far this year, China has 37innovative medicine<\/a>In addition, 51 innovative medical devices have been approved for marketing.<\/p>\n

\"Since the 14th Five-Year Plan, the quantity and quality of China's domestically produced innovative medicines have risen simultaneously, with a total of 113 domestically produced innovative medicines approved for marketing, which is 2.8 times the number of new medicines approved in the 13th Five-Year Plan.Market size of $100 billion<\/strong>.<\/p>\n

\"Since the 14th Five-Year Plan, China's high-end medical devices have accelerated innovation and breakthroughs, and a total of 165 innovative medical devices developed by Chinese enterprises have been approved for listing.Products incorporate the use of deep learning, magnetic levitation, additive manufacturing and other cutting-edge technologies.<\/strong>.<\/p>\n

During the \"14th Five-Year Plan\" period, there are 13,000 pharmaceutical industry enterprises above the scale in China, which can produce more than 20,000 kinds of drugs and medical devices.<\/p>","protected":false},"excerpt":{"rendered":"

According to CCTV News, the 2024 China Pharmaceutical Industry Development Conference held in Shanghai on November 16th revealed that the number of new drugs under research in China has jumped to the second place in the world. In September this year, the national pharmaceutical industry value-added growth rate reached 10.5%, accounting for the proportion of all industry reached 3.7%. Minister of Industry and Information Technology Jin Zhuanglong said that to speed up the process of industrialization of major innovative products, integrated complementary and strong chain, and solidly carry out the upstream and downstream of the industry chain to collaborate in the research and promote the transformation of cutting-edge technologies, such as biosynthesis, gene editing, AI pharmaceuticals and other cutting-edge technologies. The Ministry of Industry and Information Technology said that the next step will be to promote the transformation and upgrading of the pharmaceutical industry, enhance the capacity of pharmaceutical production and supply, strengthen the research and development and production of drugs in clinical shortages, children's drugs and drugs for rare diseases, increase the production capacity reserve, and further expand the opening up of the pharmaceutical industry.<\/p>","protected":false},"author":1,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[146],"tags":[4958,4959],"collection":[],"class_list":["post-23289","post","type-post","status-publish","format-standard","hentry","category-news","tag-ai","tag-4959"],"acf":[],"_links":{"self":[{"href":"https:\/\/www.1ai.net\/en\/wp-json\/wp\/v2\/posts\/23289","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.1ai.net\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.1ai.net\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.1ai.net\/en\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.1ai.net\/en\/wp-json\/wp\/v2\/comments?post=23289"}],"version-history":[{"count":0,"href":"https:\/\/www.1ai.net\/en\/wp-json\/wp\/v2\/posts\/23289\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.1ai.net\/en\/wp-json\/wp\/v2\/media?parent=23289"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.1ai.net\/en\/wp-json\/wp\/v2\/categories?post=23289"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.1ai.net\/en\/wp-json\/wp\/v2\/tags?post=23289"},{"taxonomy":"collection","embeddable":true,"href":"https:\/\/www.1ai.net\/en\/wp-json\/wp\/v2\/collection?post=23289"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}